Efficacy of nivolumab and ipilimumab in patients with malignant pleural mesothelioma is related to a subtype of effector memory cytotoxic T cells: Translational evidence from two clinical trials

Joanne Mankor; MJ Disselhorst; Myrthe Poncin; P Baas; Joachim Aerts; Heleen Vroman

doi:10.1016/j.ebiom.2020.103040

Efficacy of nivolumab and ipilimumab in patients with malignant pleural mesothelioma is related to a subtype of effector memory cytotoxic T cells: Translational evidence from two clinical trials

Joanne Mankor, MJ Disselhorst, Myrthe Poncin, P Baas, Joachim Aerts, Heleen Vroman

Pulmonary Medicine

Research output: Contribution to journal › Article › Academic › peer-review

18 Citations (Scopus)

1 Downloads (Pure)

Original language	English
Article number	103040
Journal	EBioMedicine
Volume	62
DOIs	https://doi.org/10.1016/j.ebiom.2020.103040
Publication status	Published - 2020

Access to Document

10.1016/j.ebiom.2020.103040

Repub_133785_O-A.pdfFinal published version, 1.39 MB

http://hdl.handle.net/1765/133785

Cite this

@article{c9fb6c0324d843709f6f44f0519fecc6,

title = "Efficacy of nivolumab and ipilimumab in patients with malignant pleural mesothelioma is related to a subtype of effector memory cytotoxic T cells: Translational evidence from two clinical trials",

author = "Joanne Mankor and MJ Disselhorst and Myrthe Poncin and P Baas and Joachim Aerts and Heleen Vroman",

year = "2020",

doi = "10.1016/j.ebiom.2020.103040",

language = "English",

volume = "62",

journal = "EBioMedicine",

issn = "2352-3964",

publisher = "Elsevier",

}

Efficacy of nivolumab and ipilimumab in patients with malignant pleural mesothelioma is related to a subtype of effector memory cytotoxic T cells: Translational evidence from two clinical trials. / Mankor, Joanne; Disselhorst, MJ; Poncin, Myrthe et al.

In: EBioMedicine, Vol. 62, 103040, 2020.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Efficacy of nivolumab and ipilimumab in patients with malignant pleural mesothelioma is related to a subtype of effector memory cytotoxic T cells: Translational evidence from two clinical trials

AU - Mankor, Joanne

AU - Disselhorst, MJ

AU - Poncin, Myrthe

AU - Baas, P

AU - Aerts, Joachim

AU - Vroman, Heleen

PY - 2020

Y1 - 2020

U2 - 10.1016/j.ebiom.2020.103040

DO - 10.1016/j.ebiom.2020.103040

M3 - Article

VL - 62

JO - EBioMedicine

JF - EBioMedicine

SN - 2352-3964

M1 - 103040

ER -